HMGB1 and myocardial infarction: HMGB1 can attenuate mitochondrial dysfunction and apoptosis during doxorubicin-induced cardiomyopathy32, and administration of exogenous HMGB1 at 4 h after myocardial infarction improves cardiac function33.